Other disclosuresNSE · BLISSGVS
Bliss GVS Pharma Limited
General Updates
01 / The disclosure
What the company shared
Bliss GVS Pharma Limited has informed the Exchange about the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29, 2026, the members has granted 2,95,000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019.
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106834813
- First collected
- 29 Oct 2026, 18:03 IST
- PDF extraction
- metadata_only
You’ve reached the end of this disclosure.